コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ced ventricular arrhythmia and sudden death (catecholaminergic polymorphic ventricular tachycardia).
2 ic arrhythmia syndromes (e.g., flecainide in catecholaminergic polymorphic ventricular tachycardia).
3 ) gene have been identified in patients with catecholaminergic polymorphic ventricular tachycardia.
4 phenotype and lengthy delay to diagnosis in catecholaminergic polymorphic ventricular tachycardia.
5 o define treatment outcomes in children with catecholaminergic polymorphic ventricular tachycardia.
6 reduces risk in long-QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia.
7 t cardiac sympathetic denervation in LQTS or catecholaminergic polymorphic ventricular tachycardia.
8 r in heart failure, cardiac hypertrophy, and catecholaminergic polymorphic ventricular tachycardia.
9 rt diseases, such as the long-QT syndrome or catecholaminergic polymorphic ventricular tachycardia.
10 a variety of cardiac arrhythmias, including catecholaminergic polymorphic ventricular tachycardia.
11 ch as long QT syndrome, Brugada Syndrome, or Catecholaminergic Polymorphic Ventricular Tachycardia.
12 o provide a new arrhythmogenic mechanism for catecholaminergic polymorphic ventricular tachycardia.
13 syncope in his brother raised suspicion for catecholaminergic polymorphic ventricular tachycardia.
14 receptor-2 mutation that was consistent with catecholaminergic polymorphic ventricular tachycardia.
15 ng neighboring myocytes, and correlated with catecholaminergic polymorphic ventricular tachycardia.
16 ethylenedioxymethamphetamine, marijuana, and catecholaminergic polymorphic ventricular tachycardia.
17 ctric dysfunction in an established model of catecholaminergic polymorphic ventricular tachycardia.
18 me, short QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia.
19 at position 307 in CASQ2 has been linked to catecholaminergic polymorphic ventricular tachycardia.
20 /18 (72%); long QT syndrome, 3/18 (17%); and catecholaminergic polymorphic ventricular tachycardia, 2
21 s (long QT syndrome, 9; Brugada syndrome, 8; catecholaminergic polymorphic ventricular tachycardia, 3
22 sis (17%), including Long-QT syndrome (13%), catecholaminergic polymorphic ventricular tachycardia (4
23 ence (10; 21%) and disease factors (18; 38%; catecholaminergic polymorphic ventricular tachycardia [6
24 ythmia, idiopathic ventricular fibrillation, catecholaminergic polymorphic ventricular tachycardia, a
25 practicing cardiologists: long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, a
26 ac calsequestrin (CASQ2) genes are linked to catecholaminergic polymorphic ventricular tachycardia, a
27 : 14 Brugada syndrome; 4 long-QT syndrome; 1 catecholaminergic polymorphic ventricular tachycardia; a
28 rited and acquired cardiac diseases, such as catecholaminergic polymorphic ventricular tachycardia an
29 Our data highlighted the predominant role of catecholaminergic polymorphic ventricular tachycardia an
30 The main etiologies established were catecholaminergic polymorphic ventricular tachycardia an
31 receptor 2 (RyR2) have been associated with catecholaminergic polymorphic ventricular tachycardia an
32 l and structural properties of wild-type and catecholaminergic polymorphic ventricular tachycardia-as
33 pathogenic mutations in long QT syndrome and catecholaminergic polymorphic ventricular tachycardia-as
34 Catecholaminergic polymorphic ventricular tachycardia (C
35 ed with severe forms of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia (C
36 These arrhythmias include catecholaminergic polymorphic ventricular tachycardia (C
37 ize that mimickers of concealed LQT1, namely catecholaminergic polymorphic ventricular tachycardia (C
38 el function have recently been identified in catecholaminergic polymorphic ventricular tachycardia (C
39 sm of therapeutic efficacy of flecainide for catecholaminergic polymorphic ventricular tachycardia (C
40 cardiac RyR (RyR2) mutations associated with catecholaminergic polymorphic ventricular tachycardia (C
41 Catecholaminergic polymorphic ventricular tachycardia (C
42 es associated with sudden death-predisposing catecholaminergic polymorphic ventricular tachycardia (C
43 In catecholaminergic polymorphic ventricular tachycardia (C
44 associated with atrial fibrillation (AF) and catecholaminergic polymorphic ventricular tachycardia (C
45 Catecholaminergic polymorphic ventricular tachycardia (C
46 d mutations in CaM cause arrhythmias such as catecholaminergic polymorphic ventricular tachycardia (C
47 Catecholaminergic polymorphic ventricular tachycardia (C
48 Current mechanisms of arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia (C
49 ch as congenital long-QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (C
50 Catecholaminergic polymorphic ventricular tachycardia (C
51 present with divergent clinical features of catecholaminergic polymorphic ventricular tachycardia (C
52 yanodine Receptor gene (RYR2) cause dominant catecholaminergic polymorphic ventricular tachycardia (C
53 Long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (C
54 Catecholaminergic polymorphic ventricular tachycardia (C
55 ne receptor (RyR2) mutations associated with catecholaminergic polymorphic ventricular tachycardia (C
56 Catecholaminergic polymorphic ventricular tachycardia (C
57 Catecholaminergic polymorphic ventricular tachycardia (C
58 ced pluripotent stem cells (hiPSCs) model of catecholaminergic polymorphic ventricular tachycardia (C
59 lymorphic ventricular tachycardia in humans [catecholaminergic polymorphic ventricular tachycardia (C
60 es, we propose a molecular mechanism for the catecholaminergic polymorphic ventricular tachycardia (C
61 ing that point mutation R33Q leads to lethal catecholaminergic polymorphic ventricular tachycardia (C
62 e of arrhythmogenic Ca(2+) release events in catecholaminergic polymorphic ventricular tachycardia (C
63 Catecholaminergic polymorphic ventricular tachycardia (C
64 Mutations in RYR2 cause type 1 catecholaminergic polymorphic ventricular tachycardia (C
65 Catecholaminergic polymorphic ventricular tachycardia (C
66 ercise-induced arrhythmias (in patients with catecholaminergic polymorphic ventricular tachycardia [C
67 netic form of exercise-induced sudden death (catecholaminergic polymorphic ventricular tachycardia [C
68 ed to exercise-induced sudden cardiac death (catecholaminergic polymorphic ventricular tachycardia [C
69 thal cardiac arrhythmia syndromes, including catecholaminergic polymorphic ventricular tachycardia, c
70 Foremost are those with catecholaminergic polymorphic ventricular tachycardia du
71 In catecholaminergic polymorphic ventricular tachycardia, e
72 (2/10) and 50% of long QT syndrome (1/2) and catecholaminergic polymorphic ventricular tachycardia fa
73 es have been used to study long QT syndrome, catecholaminergic polymorphic ventricular tachycardia, h
74 ism of Ca(2+) release dysfunction underlying catecholaminergic polymorphic ventricular tachycardia ha
75 me, short-QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia ha
76 Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in
77 Catecholaminergic polymorphic ventricular tachycardia is
78 The recessive form of catecholaminergic polymorphic ventricular tachycardia is
79 ardiac calsequestrin-2 gene; this variant of catecholaminergic polymorphic ventricular tachycardia is
80 Catecholaminergic polymorphic ventricular tachycardia is
81 Catecholaminergic polymorphic ventricular tachycardia is
82 Catecholaminergic polymorphic ventricular tachycardia is
83 Catecholaminergic polymorphic ventricular tachycardia is
84 Catecholaminergic polymorphic ventricular tachycardia is
85 ssion of a canine CASQ2 protein carrying the catecholaminergic polymorphic ventricular tachycardia-li
86 AN [Ca(2+)](i) handling in mice carrying the catecholaminergic polymorphic ventricular tachycardia-li
87 iac myocytes of heterozygous mice carrying a catecholaminergic polymorphic ventricular tachycardia-li
88 We have shown that catecholaminergic polymorphic ventricular tachycardia-li
89 Patients with catecholaminergic polymorphic ventricular tachycardia ma
90 e-threatening arrhythmias in CASQ2-defective catecholaminergic polymorphic ventricular tachycardia mi
91 ed properties not previously identified in a catecholaminergic polymorphic ventricular tachycardia mo
92 ntials and diastolic contractions (DCs) in a catecholaminergic polymorphic ventricular tachycardia mo
93 Patients with LQTS (N=40) and catecholaminergic polymorphic ventricular tachycardia (N
94 spectrum of arrhythmogenic disease included catecholaminergic polymorphic ventricular tachycardia (n
95 y multicenter, retrospective cohort study of catecholaminergic polymorphic ventricular tachycardia pa
96 injection, analogous to what was observed in catecholaminergic polymorphic ventricular tachycardia pa
97 tions contributing to the SAN dysfunction in catecholaminergic polymorphic ventricular tachycardia pa
98 patients diagnosed with long QT syndrome and catecholaminergic polymorphic ventricular tachycardia re
99 tibility genes (KCNQ1, KCNH2, and SCN5A) and catecholaminergic polymorphic ventricular tachycardia-su
100 nelopathies (short and long QT, Brugada, and catecholaminergic polymorphic ventricular tachycardia sy
101 we simulated mutations in 2 genes linked to catecholaminergic polymorphic ventricular tachycardia, t
102 DEP and sudden cardiac death cases linked to catecholaminergic polymorphic ventricular tachycardia th
103 Catecholaminergic polymorphic ventricular tachycardia ty
104 rillator (ICD) therapy for the management of catecholaminergic polymorphic ventricular tachycardia (V
105 rdiac arrest, including long-QT syndrome and catecholaminergic polymorphic ventricular tachycardia (V
106 Catecholaminergic polymorphic ventricular tachycardia (V
107 A specific genetic test for catecholaminergic polymorphic ventricular tachycardia wa
108 ogenic right ventricular cardiomyopathy, and catecholaminergic polymorphic ventricular tachycardia we
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。